TP53 and neoplasm: Shared CNV breakpoints and altered haplotypes indicated that tumours derived from 20-week post-WGD RPE TP53−/− cells originated from the selection and expansion of the same clone in vivo (Fig. 4d,e and Extended Data Fig. 8c).